News & Events
21 Feb 2019
Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies
NEWS – DUBLIN & BOURNEMOUTH, 21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announce a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines.
Valitacell’s novel in-line analytical profiling technologies and its data driven/machine learning approach, together with Solentim’s innovative image-driven liquid handling and cell measurement technology, will transform current workflows, creating a streamlined, automated platform which synergises precise cell manipulations, attribute-rich profiling of clones and earlier decision making.
"This collaboration combines our expertise in both biotherapeutics and emergent cellular therapy, and will optimise the process of drug discovery. We look forward to working in partnership with Solentim as we continue to discover and develop life-saving medicines that improve patients’ lives", said Dr. Terry McWade, CEO of Valitacell.
Dr Ian Taylor, Chief Commercial Officer of Solentim, added, “We are delighted to be collaborating with Valitacell – this combination of technologies will provide a further component to our unique integrated solution for accelerating stable cell line development workflows. It will provide significant benefits for richer clone information and earlier decision-making on the best candidates to progress.
Further details of the collaboration will be announced in the coming weeks.
06 Feb 2019
Valitacell Ltd and Andrew Alliance SA Collaborate to Automate Critical Aspects of Cell Line Development
Valitacell are excited to announce the strategic partnership with Andrew Alliance to automate critical aspects of the cell line development pathway & efficiently optimize laboratory processes to make intelligent, data driven decisions during the drug development process. Read the full press release here.
05 Feb 2019
We are pleased to feature in the NIBRT 2018 annual report as industry-aligned research collaborators, amongst leaders such as Thermo Fisher Scientific, Siemens and Kerry. You can download the full report below.
04 Feb 2018
Valitacell Trending Series: Automation in Biopharma
Our suite of technologies are fully automatable to enable optimised workflows, that’s why we are shining a light on the growing opportunities in bioprocess automation, as biotherapeutic manufacturers consider their automation strategy. . Watch Valitacell expert Dr Hannah Byrne discuss how automation is changing drug manufacturing as we know it.
07 Jan 2018
We’re delighted to announce another patent approval - this time for the Quantum platform - ValitaTITER which can now quantify up to 1.5 g/L of antibody!
11 Dec 2018
We're looking forward to presenting at this years ACTIP meeting in Stockholm. The event covers cutting-edge developments in research and production related to animal cell technology.
06 Dec 2018
Check out our recent publication on ChemStress Fingerprinting in the International Biopharmaceutical Industry Journal on how to introduce biomanufacturing process control.
28 Nov 2018
Another Patent Approval! We're announcing the European patent approval for a method of determining a compositional or functional characteristic of cell culture media.
Watch Valitacell expert Dr Karen Coss explain the current importance of cell culture media, the challenges that exist, bespoke media and how our ChemStress Fingerprinting technology can benefit the industry.
01 Nov 2018
We’re delighted to announce our Innovation partnership with NIBRT to innovate the way that life-saving medicines are made. The Enterprise Ireland co-funded initiative will help innovate the production of new biopharma therapies for patients.
01 Nov 2018
Valitacell Trending Series: Cell Culture Media: Current challenges, bespoke media and ChemStress
Watch Valitacell expert Dr Karen Coss explain the current challenges that exist in the market, the role that bespoke media has to play and how Valitacell’s ChemStress technology can offer process control of the media environment.
12 Oct 2018
This week we’ve been hosting our UK team and advisors on-site for the Valitacell technical symposium!
08 Oct 2018
Come meet us at the Bioproduction’s Bioanalytical and formulation Summit at Booth 62, don’t miss our podium presentation in the Cell Line Development and Engineering stream.
21 Sept 2018
Catch Valitacell CEO Dr Terry mcWade - presenting at the EIC innovators summit in Berlin
03 Sept 2018
We are looking forward to sponsoring the upcoming Bioproduction Congress in Dublin. Catch our talk on Monday the 8th of October at 10.30 with data expert Dr Paul Dobson.
01 Sept 2018
Another Patent Approval! We're announcing the European patent approval for a method of predicting phenotypic instability in a cell.
26 Aug 2018
Looking forward to The Bioprocessing Summit in Boston! Join us at booth 212 and don't miss our podium presentation!
3 Jul 2018
Valitacell presents at the CALIN R&D and Innovation support for life sciences
7 Jun 2018
17 May 2018
Thanks for visiting us at Cell Line Development & Engineering Asia, in Shanghai.
08 May 2018
Attending Cell Line Development & Engineering Asia in May? Join us at Booth 24, or at one of our selected podium and poster presentations..
25 Apr 2018
Thanks for joining us at BPI Europe where our technical expert Dr Hannah Byrne presented our novel analytical technologies for cell line development.
10 Apr 2018
Join us at Booth 93 at BPI Europe
20 Mar 2018
Join us at the Bioprocessing Summit Lisbon? Join us at Booth 11!
11 Mar 2018
Attending the Bioprocessing Summit? Join us at booth 11 or at one of our selected talks: https://us14.campaign-archive.com/?e=&u=c29faf76574586861ff1dc549&id=9186f76bd1
26 Jan 2018
Tecan publish application note on the ValitaTITER assay - download here > Download
16 Jan 2018
Molecular Devices publish application note on Streamlining the workflow for measuring IgG in cell line development using ValitaTITER
You can find out more by downloading the PDF here.
27 Nov 2017
BMG Labtech publish application note on the ValitaTITER assay
Download the PDF here.
15 Nov 2017
ValitaTITER featured in the Fall issue of BioTek TekTalk series
Catch up on the latest issue here .
6 Oct 2017
Valitacell awarded 'Pharma Start-up of the year' by the Irish Pharma Awards
19 Sept 2017
Valitacell will be exhibiting at biotech week boston booth #1027
Catch us at BPI booth #1027 or check out Professor David James' talk on Sept. 28th at 8.15am on 'How to harness & measure CHO cell genetic and functional instability for improving cell factory performance'.
15 Sept 2017
Valitacell's ChemStress featured in GEN article on 'Solving the puzzle of cell culture optimization'
Genetic Engineering and Biotechnology News GEN has featured Valitacells technology ChemStress in a recent article on how 'assembling a jigsaw puzzle is not nearly as tricky as tricky as building a stable and productive bioprocess', and how ChemStress is helping solve this problem. Read the article in full here.
14 Sept 2017
Valitacell Profile in Irish Times as finalists for The Irish Times Innovation Award
17 Aug 2017
Valitacell Publish paper in Analytical biochemistry
The publication entitled 'High-throughput quantitation of Fc-containing Recombinant Proteins in cell culture supernatant by fluorescence polarisation spectroscopy' can be downloaded in full here.
15 Aug 2017
Valitacell shortlisted for three prizes at the pharma awards
Valitacell has been nominated for three awards at this years Pharma Awards
07 Aug 2017
valitacell are attending the Bioprocessing Summit, Boston, Find us at Booth #604
Valitacell will be attending the 9th annual Bioprocessing Summit in Boston this year from the 21st - 25th August. Say hello!
17 Jul 2017
valitacell named Ones to Watch by business and finance
Business and Finance has highlighted Valitacell as one of the top movers and shakers in the country. Read full profile here.
To access the Valitacell news archives, click below: